Back to Search
MICHAEL BRAWER, MD
MD
Urology Physician
NPI: 1295712651Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
MD00026431(WA)
Research & Publications (20)
New treatments for castration-resistant prostate cancer: highlights from the 44th annual meeting of the american society of clinical oncology, may 30-june 3, 2008, chicago, IL.
PMID 19145273·Rev Urol·2008
8-other
Recent Progress in the Treatment of Advanced Prostate Cancer With Intermittent Dose-Intense Calcitriol (DN-101).
PMID 17396166·Rev Urol·2007
8-other
A Multicenter Study on the Efficacy and Safety of Interstitial Laser Coagulation Versus alpha-Blockade in Subjects With Symptomatic Benign Prostatic Hyperplasia: Preliminary Results.
PMID 16985901·Rev Urol·2005
8-other
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the Early Prostate Cancer Program.
PMID 12656893·BJU Int·2003
8-other
Clinical usefulness of assays for complexed prostate-specific antigen.
PMID 12109345·Urol Clin North Am·2002
6-review
Treatment of clinically localized prostatic carcinoma: helping our patients make an informed decision.
PMID 12497057·Prostate Cancer Prostatic Dis·2001
8-other
Perspectives on prostate cancer diagnosis and treatment: a roundtable.
PMID 11489681·Urology·2001
8-other
Prostate cancer: where we have been, where we are, where we are going.
PMID 11071462·World J Surg·2000
6-review
Long-term stability of alpha-1-antichymotrypsin complexed form of prostate specific antigen.
PMID 12497096·Prostate Cancer Prostatic Dis·2000
8-other
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
PMID 10751861·J Urol·2000
4-observational
Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.
PMID 19680529·Rev Urol·2009
8-other
The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
PMID 18783735·Contemp Clin Trials·2009
4-observational
Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL.
PMID 18660856·Rev Urol·2008
8-other
Best of the 2007 AUA Annual Meeting: Highlights from the 2007 Annual Meeting of the American Urological Association, May 19-24, 2007, Anaheim, CA.
PMID 17934570·Rev Urol·2007
8-other
Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program.
PMID 15833513·Urology·2005
8-other
Lonidamine: basic science and rationale for treatment of prostatic proliferative disorders.
PMID 16986057·Rev Urol·2005
8-other
Androgen deprivation therapy: a cornerstone in the treatment of advanced prostate cancer.
PMID 16985918·Rev Urol·2004
8-other
Challenges with luteinizing hormone-releasing hormone agonists: flare and surge.
PMID 16985931·Rev Urol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1570 N 115TH ST, SUITE PB 15
SEATTLE, WA 98133 - Phone
- (206) 368-6591
Quick Facts
- NPI
- 1295712651
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile